|
1
|
Huang SH and O'Sullivan B: Oral cancer:
Current role of radiotherapy and chemotherapy. Med Oral Patol Oral
Cir Bucal. 18:e233–e240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mansoori B, Mohammadi A, Davudian S,
Shirjang S and Baradaran B: The different mechanisms of cancer drug
resistance: A brief review. Adv Pharm Bull. 7:339–348. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagasubramanian R, Innocenti F and Ratain
MJ: Pharmacogenetics in cancer treatment. Annu Rev Med. 54:437–452.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nussinov R, Tsai CJ and Jang H: Anticancer
drug resistance: An update and perspective. Drug Resist Updat.
59:1007962021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lugones Y, Loren P and Salazar LA:
Cisplatin resistance: Genetic and epigenetic factors involved.
Biomolecules. 12:13652022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lewis JD, Payton LA, Whitford JG, Byrne
JA, Smith DI, Yang L and Bright RK: Induction of tumorigenesis and
metastasis by the murine orthologue of tumor protein D52. Mol
Cancer Res. 5:133–144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dasari C, Reddy KRK, Natani S, Murthy TRL,
Bhukya S and Ummanni R: Tumor protein D52 (isoform 3) interacts
with and promotes peroxidase activity of Peroxiredoxin 1 in
prostate cancer cells implicated in cell growth and migration.
Biochim Biophys Acta Mol Cell Res. 1866:1298–1309. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shehata M, Bièche I, Boutros R,
Weidenhofer J, Fanayan S, Spalding L, Zeps N, Byth K, Bright RK,
Lidereau R and Byrne JA: Nonredundant functions for tumor protein
D52-like proteins support specific targeting of TPD52. Clin Cancer
Res. 14:5050–5060. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mukudai Y, Kondo S, Fujita A, Yoshihama Y,
Shirota T and Shintani S: Tumor protein D54 is a negative regulator
of extracellular matrix-dependent migration and attachment in oral
squamous cell carcinoma-derived cell lines. Cell Oncol (Dordr).
36:233–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abe Y, Mukudai Y, Kurihara M, Houri A,
Chikuda J, Yaso A, Kato K, Shimane T and Shirota T: Tumor protein
D52 is upregulated in oral squamous carcinoma cells under hypoxia
in a hypoxia-inducible-factor-independent manner and is involved in
cell death resistance. Cell Biosci. 11:1222021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Houri A, Mukudai Y, Abe Y, Watanabe M,
Nara M, Miyamoto S, Kurihara M, Shimane T and Shirota T: Suprabasin
enhances the invasion, migration, and angiogenic ability of oral
squamous cell carcinoma cells under hypoxic conditions. Oncol Rep.
49:832023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watanabe M, Mukudai Y, Kindaichi N, Nara
M, Yamada K, Abe Y, Houri A, Shimane T and Shirota T: Tumor protein
D53 (TPD53): Involvement in malignant transformation of
low-malignant oral squamous cell carcinoma cells. Biomedicines.
12:27252024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Momose F, Araida T, Negishi A, Ichijo H,
Shioda S and Sasaki S: Variant sublines with different metastatic
potentials selected in nude mice from human oral squamous cell
carcinomas. J Oral Pathol Med. 18:391–395. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kapuscinski J: DAPI: A DNA-specific
fluorescent probe. Biotech Histochem. 70:220–233. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsui A, Ihara T, Suda H, Mikami H and
Semba K: Gene amplification: Mechanisms and involvement in cancer.
Biomol Concepts. 4:567–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Braconi L, Riganti C, Parenti A, Cecchi M,
Nocentini A, Bartolucci G, Menicatti M, Contino M, Colabufo NA,
Manetti D, et al: Dual inhibitors of P-gp and carbonic anhydrase
XII (hCA XII) against tumor multidrug resistance with piperazine
scaffold. Molecules. 29:32902024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fenyvesi F, Fenyvesi E, Szente L, Goda K,
Bacsó Z, Bácskay I, Váradi J, Kiss T, Molnár E, Janáky T, et al:
P-glycoprotein inhibition by membrane cholesterol modulation. Eur J
Pharm Sci. 34:236–242. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee CY, Lai TY, Tsai MK, Ou-Yang P, Tsai
CY, Wu SW, Hsu LC and Chen JS: The influence of a caveolin-1 mutant
on the function of P-glycoprotein. Sci Rep. 6:204862016. View Article : Google Scholar : PubMed/NCBI
|
